Globus Medical Stock: Re-Rated After A Solid Year [Seeking Alpha]
Globus Medical, Inc. Class A (GMED)
Last globus medical, inc. class a earnings: 2/20 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.globusmedical.com
Company Research
Source: Seeking Alpha
Follow Play 8min Summary Globus Medical, Inc.'s stock has surged due to a successful execution of the NuVasive deal and three consecutive guidance hikes, boosting investor confidence and valuation. The $3.1 billion acquisition of NuVasive doubled sales, with projected synergies expected to significantly enhance earnings in the coming years. Despite solid performance and improved guidance, the stock's re-rating to $81 suggests that easy money has been made, prompting profit-taking. Looking for a helping hand in the market? Members of Value In Corporate Events get exclusive ideas and guidance to navigate any climate. Learn More » The Good Brigade Shares of Globus Medical, Inc. ( GMED have seen healthy gains, a little over a year, since the deal with NuVasive closed. Early this year, I concluded that dis-synergies in connection to the merger If you like to see more ideas, please subscribe to the premium service "Value in Corporate Events" here and try the free trial.
Show less
Read more
Impact Snapshot
Event Time:
GMED
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GMED alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GMED alerts
High impacting Globus Medical, Inc. Class A news events
Weekly update
A roundup of the hottest topics
GMED
News
- ILMN Stock Set to Gain From Expansion of TruSight Oncology Portfolio [Yahoo! Finance]Yahoo! Finance
- Globus Medical, Inc. (NYSE: GMED) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Globus Medical (GMED) is a Top-Ranked Momentum Stock: Should You Buy? [Yahoo! Finance]Yahoo! Finance
- Is Globus Medical (GMED) a Solid Growth Stock? 3 Reasons to Think "Yes" [Yahoo! Finance]Yahoo! Finance
- Expanding Global Market, NuVasive Benefits to Aid GMED Stock [Yahoo! Finance]Yahoo! Finance
GMED
Earnings
- 11/5/24 - Beat
GMED
Sec Filings
- 11/21/24 - Form 144
- 11/21/24 - Form 144
- 11/21/24 - Form 144
- GMED's page on the SEC website